Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | EDNRA | P25101 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | MAOB | P27338 | 12/20 | 0.39 |
| ▸ | MAOA | P21397 | 11/20 | 0.39 |
| ▸ | KDM1A | O60341 | 9/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 4/20 | 0.38 |
| ▸ | CYP2B6 | P20813 | 3/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | HTR1A | P08908 | 1/20 | 0.38 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.38 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.38 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.38 |
| ▸ | HTR2C | P28335 | 1/20 | 0.38 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10843954 | 0.71 | SMN1; SMN2 (0.65) | SMN1; SMN2EDNRATSHRCYP1A2LMNA | |
| SCHEMBL22012817 | 0.67 | SMN1; SMN2 (0.38) | SMN1; SMN2EDNRACYP1A2LMNACYP3A4 | |
| SCHEMBL2031804 | 0.67 | HDAC4 (0.46) | TSHRMAOBMAOAKDM1ACYP2C19 | |
| SCHEMBL31041077 | 0.67 | HDAC4 (0.46) | TSHRMAOBMAOAKDM1ACYP2C19 | |
| SCHEMBL22732971 | 0.65 | SMN1; SMN2 (0.52) | SMN1; SMN2EDNRACYP1A2LMNACYP3A4 | |
| SCHEMBL15580875 | 0.65 | SMN1; SMN2 (0.58) | SMN1; SMN2EDNRATSHRCYP1A2LMNA | |
| SCHEMBL12474357 | 0.65 | SMN1; SMN2 (0.52) | SMN1; SMN2EDNRACYP1A2LMNACYP3A4 | |
| SCHEMBL16689762 | 0.65 | SMN1; SMN2 (0.58) | SMN1; SMN2EDNRATSHRCYP1A2LMNA | |
| SCHEMBL30149221 | 0.65 | HDAC4 (0.44) | TSHRMAOBMAOAKDM1ACYP2C19 | |
| SCHEMBL7556279 | 0.63 | LMNA (0.46) | MAOBMAOAKDM1ACYP2C19CYP2B6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12044872-B2 | Method for generating alignment on top of a liquid crystal polymer material | Rolic Technologies AG (CH) | 2024-07-23 | — | — | US | disclosed |
| US-12012382-B2 | Polymerizable liquid crystal having a carbazole core | Rolic Technologies AG (CH) | 2024-06-18 | — | — | US | disclosed |
| US-12006463-B2 | Polymerizable liquid crystal having a quinoxaline-hydrazone core | Rolic Technologies AG (CH) | 2024-06-11 | — | — | US | disclosed |
| US-11952524-B2 | Compositions of polymerizable liquid crystals | Rolic Technologies AG (CH) | 2024-04-09 | — | — | US | disclosed |
| EP-3175493-B1 | ENCAPSULATION STRUCTURE FOR AN OLED DISPLAY INCORPORATING ANTIREFLECTION PROPERTIES | BASF COATINGS GMBH (DE) | 2024-03-06 | — | — | EP | disclosed |
| EP-3990568-B1 | NEW POLYMERIZABLE LIQUID CRYSTAL HAVING A QUINOXALINE-HYDRAZONE CORE | ROLIC TECH AG (CH) | 2023-11-15 | — | — | EP | disclosed |
| US-11702595-B2 | Polymerizable liquid crystal | Rolic Technologies AG (CH) | 2023-07-18 | — | — | US | disclosed |
| EP-3126883-B1 | OPTICAL DEVICES WITH PATTERNED ANISOTROPY INCORPORATING PARALLAX OPTIC | ROLIC TECH AG (CH) | 2023-07-12 | — | — | EP | disclosed |
| US-20220228063-A1 | NEW POLYMERIZABLE LIQUID CRYSTAL | Rolic Technologies AG (CH) | 2022-07-21 | — | — | US | disclosed |
| US-20220163853-A1 | PHOTO-ALIGNABLE POSITIVE C-PLATE RETARDER | Rolic Technologies AG (CH) | 2022-05-26 | — | — | US | disclosed |
| US-20150109597-A1 | FAST GENERATION OF ELEMENTS WITH INDIVIDUALLY PATTERNED ANISOTROPY | ROLIC AG (CH) | 2015-04-23 | — | — | US | disclosed |
| US-20140226115-A1 | PHOTO-ALIGNMENT LAYERS WITH STRONG UV-DICHROISM | ROLIC AG (CH) | 2014-08-14 | — | — | US | disclosed |
| EP-2067064-B1 | VOLUME PHOTO-ALIGNED RETARDER | ROLIC AG (CH) | 2014-06-11 | — | — | EP | disclosed |
| US-8574454-B2 | Patternable liquid crystal polymer comprising thio-ether units | ROLIC AG (CH) | 2013-11-05 | — | — | US | disclosed |
| EP-2094815-B1 | PATTERNABLE LIQUID CRYSTAL POLYMER COMPRISING THIO-ETHER UNITS | ROLIC AG (CH) | 2012-06-27 | — | — | EP | disclosed |
| US-8054411-B2 | Volume photo-aligned retarder | ROLIC AG (CH) | 2011-11-08 | — | — | US | disclosed |
| US-20100266814-A1 | PHOTOALIGNMENT COMPOSITION | ROLIC AG (CH) | 2010-10-21 | — | — | US | disclosed |
| US-20100266821-A1 | FUNCTIONALIZED PHOTOREACTIVE COMPOUNDS | ROLIC AG (CH) | 2010-10-21 | — | — | US | disclosed |
| US-20100059709-A1 | PATTERNABLE LIQUID CRYSTAL POLYMER COMPRISING THIO-ETHER UNITS | ROLIC AG (CH) | 2010-03-11 | — | — | US | disclosed |
| US-20100026935-A1 | VOLUME PHOTO-ALIGNED RETARDER | ROLIC AG (CH) | 2010-02-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12012382-B2 | Polymerizable liquid crystal having a carbazole core | FZD7, CCL11, SGK2 | SMN1; SMN2 4742/4885EDNRA 3262/4885TSHR 4670/4885 |
| US-12006463-B2 | Polymerizable liquid crystal having a quinoxaline-hydrazone core | AQP1, AQP4, HCN1 | SMN1; SMN2 4753/4885EDNRA 3066/4885TSHR 4748/4885 |
| US-20100266821-A1 | FUNCTIONALIZED PHOTOREACTIVE COMPOUNDS | ETV6, TERB1, VCL | SMN1; SMN2 4497/4885EDNRA 2772/4885TSHR 2049/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.